Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

Share Price is delayed by 15 minutes
Get Live Data
25.75    0.00 (0.00%)
Bid:
25.50
Ask:
26.00
Spread: 0.50 (1.961%)
Market Cap: £129.66m
DUKE Live PriceLast checked at - London Stock Exchange

Intraday Duke Capital Share Chart

Further Contribution to Royalty Partner

13 Nov 2017 09:39

RNS Number : 2938W
Duke Royalty Limited
13 November 2017
 

13 November 2017

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

 

Duke Royalty provides follow-on contribution to Royalty Partner

 

Duke Royalty Limited (AIM: DUKE) is pleased to announce a further contribution into its royalty partner Lynx Equity (U.K.) Limited ("Lynx UK") of GBP2.5 million. Based on the increased aggregate investment of GBP 7.0 million, Duke will be entitled to higher monthly distributions ("Distributions") from Lynx UK beginning in December 2017 which will total GBP 840,000 per annum. Lynx UK has recently closed the acquisition of their third European company, PartnerService, a Danish commercial cleaning business started in 2003 by two brothers. The royalty coverage ratio in Lynx UK has been increased above 2.0x target EBITDA due to this transaction.

The Lynx UK Distributions will be paid monthly and adjusted annually with the first adjustment occurring in August 2018, based on the percentage change in Lynx UK's gross revenues for the fiscal year to July 2018 compared to the prior year. The annual adjustment in the Distributions will be subject to a collar and the term of the investment is perpetual. Duke also has a senior secured position over all present and future property and assets of Lynx UK and shares of the subsidiaries of Lynx UK and has also been granted a guarantee by Lynx UK's parent company, Lynx Equity.

With the addition of Lynx UK's third portfolio company, which like the other two has no debt, Duke now has a portfolio of four different companies contributing to its Distributions. Duke's Distributions are also diversified over four distinct industries in three countries. The aggregate capital deployed by Duke in 2017 is over GBP 14 million and from December 2017 the total monthly Distributions are over GBP 145,000.

The Company continues to make good progress on its pipeline of a number of other potential royalty partners and looks forward to updating shareholders in due course.

Neil Johnson commented: "We are delighted to make this additional investment into Lynx UK. PartnerService is a well-managed, profitable company that meets all of Duke's investment criteria. Furthermore, Lynx UK has more diversified revenue, a larger asset base and provides Duke with a larger royalty coverage ratio than before the acquisition of PartnerService. Therefore, we believe as Lynx UK grows, Duke and its shareholders benefit."

About Duke Royalty

Headquartered in Guernsey, Duke Royalty Limited provides alternative financing solutions to a diversified range of businesses in Europe and abroad. Duke Royalty's experienced team and exclusive partnership provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders.

Duke Royalty is listed on the AIM market under the ticker DUKE. For more information, visit dukeroyalty.com.

About Lynx UK

Lynx UK is a subsidiary of Lynx Equity which is a Toronto-based private firm that seeks to acquire, own and operate mature, old-economy businesses in a diverse range of industries. Over its 10-year history, Lynx has made over 40 acquisitions and grown revenue to over C$300 million per annum for its financial year ended 31 July 2017. Lynx has been recognized as one of Canada's Fastest-Growing Companies three years in a row in the PROFIT 500, the definitive ranking published by Canadian Business magazine based on five-year revenue growth. PartnerService offers commercial cleaning services to offices, schools, retail shops and other commercial institutions and has been operating profitably for over a decade and has many years of continued revenue growth.

For further information on Lynx Equity, please visit www.lynxequity.com

For further information:

Duke Royalty Limited

Neil Johnson / Charlie Cannon-Brookes

+44 (0) 1481 741 240

Grant Thornton UK LLP (Nominated Adviser)

Colin Aaronson / Samantha Harrison / Carolyn Sansom

+44 (0) 20 7383 5100

Cenkos Securities plc (Joint Broker)

Julian Morse / Michael Johnson

+44 (0) 207 397 8900

Mirabaud Securities Limited (Joint Broker)

Peter Krens / Edward Haig-Thomas

+44 (0) 20 3167 7222

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

END

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEANFDFDXXFEF
Date   Source Headline
28th May 20267:00 amRNSNotice of Results & Investor Presentation
31st Mar 20267:00 amRNSTrading and Operational Update
19th Mar 20267:00 amRNSInterim Dividend and Dividend Declaration
26th Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSFollow-On Investment into Tristone Healthcare Ltd
22nd Dec 20257:00 amRNSFollow-On Investment into Tristone Healthcare Ltd
18th Dec 20257:00 amRNSInterim Dividend and Dividend Declaration
4th Dec 20257:00 amRNSInterim Financial Results
17th Oct 20257:00 amRNSFollow-On Investment into Step Investments Limited
1st Oct 20257:00 amRNSFollow-On Investment into Integrum Group Holdings
29th Sep 20257:00 amRNSTrading Update
18th Sep 20257:00 amRNSInterim Dividend and Dividend Declaration
4th Aug 202511:17 amRNSResult of Annual General Meeting
1st Aug 20258:08 amRNSDirector/PDMR Dealings
11th Jul 20257:00 amRNSAnnual Report & Notice of Annual General Meeting
25th Jun 20257:00 amRNSFinal Results for the year ended 31 March 2025
19th Jun 20257:00 amRNSInterim Dividend and Dividend Declaration
2nd Jun 20257:00 amRNSFollow-On Investment into Existing Capital Partner
27th May 20257:00 amRNSNotice of Results & Investor Presentation
2nd Apr 20257:00 amRNSFollow-On Investment into Existing Capital Partner
31st Mar 20257:00 amRNSTrading and Operational Update
20th Mar 20257:00 amRNSInterim Dividend and Dividend Declaration
19th Feb 20257:00 amRNSFollow-On Investment into BPVA (Ireland) Limited
30th Dec 20247:00 amRNSTrading and Operational Update
17th Dec 202412:50 pmRNSInterim Dividend and Dividend Declaration
16th Dec 20247:00 amRNSInterim Results for the six months ended 30 Sep 24
4th Dec 20249:40 amRNSDirector/PDMR Shareholding
3rd Dec 202411:34 amRNSResult of General Meeting and Issue of Equity
22nd Nov 20243:38 pmRNSResult of Retail Offer and Broker Option
15th Nov 20247:00 amRNSResult of Placing
14th Nov 20245:02 pmRNSRetail Offer to raise up to £3.0 million
14th Nov 20245:01 pmRNSIssue of Equity
30th Sep 20247:00 amRNSTrading and Operational Update
19th Sep 20247:00 amRNSInterim Dividend and Dividend Declaration
3rd Sep 20247:00 amRNSFollow-On Investment into United Glass Group
1st Aug 20243:16 pmRNSDirector/PDMR Dealings
1st Aug 202411:40 amRNSResult of Annual General Meeting
22nd Jul 20247:00 amRNSFollow-On Investment into Step Investments Limited
15th Jul 20247:00 amRNSAnnual Report & Notice of Annual General Meeting
27th Jun 20247:00 amRNSFinal Results for the year ended 31 March 2024
20th Jun 202411:50 amRNSInterim Dividend and Dividend Declaration
3rd Jun 20247:00 amRNSNotice of Results
17th May 202411:45 amEQSHardman & Co Q&A on Duke Capital (DUKE) | Generating investor returns by uniquely meeting customer needs
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.